Earlier in February, the New Delhi bench of the National Company Law Tribunal (NCLT) approved the amalgamation of Shree Jee ...

There’s also an increased risk of depression. Happy Head’s oral minoxidil is a prescription-strength tablet designed to treat thinning hair and balding on the scalp. Each tablet has 2.5 ...

Top generics makers such as Cipla, Dr Reddy’s, Lupin, Natco Pharma, Mankind Pharma, and Biocon are all gearing up to launch cheaper generic copies of Ozempic. Meanwhile, India’s largest pharma ...

Under the deal, Sun Pharma will buy the outstanding shares of the Massachusetts-based company for $4.10 each, representing a premium of approximately 66% to Checkpoint’s closing share price last ...

Now dermatologists are increasingly prescribing the drug, known generically as minoxidil, in low-dose pills to help men and women maintain or regrow hair. Oral minoxidil emerges as convenient ...

A key drug in this class, semaglutide is set to go off-patent in March next year, and several Indian players, including Mankind Pharma Limited, Alkem Labs Limited, and Dr. Reddy’s Laboratories ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

Now dermatologists are increasingly prescribing the drug, known generically as minoxidil, in low-dose pills to help men and women maintain or regrow hair. The practice follows several recent studies ...

Now dermatologists are increasingly prescribing the drug, known generically as minoxidil, in low-dose pills to help men and women maintain or regrow hair. Minoxidil — a drug originally developed ...

Now dermatologists are increasingly prescribing the drug, known generically as minoxidil, in low-dose pills to help men and women maintain or regrow hair. The practice follows a handful of recent ...

Previously at the epicenter of the U.S. opioid crisis, Purdue Pharma is looking to reenter the public lexicon as a new public benefit company. After a prior bankruptcy settlement was nixed by the ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.